BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández-Ruiz J, Gómez-Ruiz M, García C, Hernández M, Ramos JA. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies. Methods Enzymol 2017;593:175-98. [PMID: 28750802 DOI: 10.1016/bs.mie.2017.06.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T. Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders. Int Rev Neurobiol 2019;146:229-57. [PMID: 31349929 DOI: 10.1016/bs.irn.2019.06.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Martínez-Pinilla E, Rubio-Sardón N, Peláez R, García-Álvarez E, Del Valle E, Tolivia J, Larráyoz IM, Navarro A. Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases. Int J Mol Sci 2021;22:1260. [PMID: 33514021 DOI: 10.3390/ijms22031260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gado F, Arena C, Fauci CL, Reynoso-moreno I, Bertini S, Digiacomo M, Meini S, Poli G, Macchia M, Tuccinardi T, Gertsch J, Chicca A, Manera C. Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system. Bioorganic Chemistry 2020;94:103353. [DOI: 10.1016/j.bioorg.2019.103353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fernández-Ruiz J. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes. Br J Pharmacol 2019;176:1370-83. [PMID: 29856067 DOI: 10.1111/bph.14382] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
5 Martínez-Pinilla E, Aguinaga D, Navarro G, Rico AJ, Oyarzábal J, Sánchez-Arias JA, Lanciego JL, Franco R. Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease. Mol Neurobiol 2019;56:5900-10. [PMID: 30687889 DOI: 10.1007/s12035-019-1495-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Chicca A, Arena C, Bertini S, Gado F, Ciaglia E, Abate M, Digiacomo M, Lapillo M, Poli G, Bifulco M, Macchia M, Tuccinardi T, Gertsch J, Manera C. Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system. Eur J Med Chem 2018;154:155-71. [PMID: 29793210 DOI: 10.1016/j.ejmech.2018.05.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
7 Pandelides Z, Thornton C, Lovitt KG, Faruque AS, Whitehead AP, Willett KL, Ashpole NM. Developmental exposure to Δ9-tetrahydrocannabinol (THC) causes biphasic effects on longevity, inflammation, and reproduction in aged zebrafish (Danio rerio). Geroscience 2020;42:923-36. [PMID: 32227279 DOI: 10.1007/s11357-020-00175-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rivera P, Fernández-Arjona MDM, Silva-Peña D, Blanco E, Vargas A, López-Ávalos MD, Grondona JM, Serrano A, Pavón FJ, Rodríguez de Fonseca F, Suárez J. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure. Biochem Pharmacol 2018;157:244-57. [PMID: 30098312 DOI: 10.1016/j.bcp.2018.08.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]